Search - tctmd.com

Displaying 181 - 200 of 320

Sort: Relevancy | Date

$Role of Brachytherapy for Refractory ISR in 2018$

Presentation TCT 2018

Role of Brachytherapy for Refractory ISR in 2018

Presenter: Fernando Alfonso, Azeem Latib, Ron Waksman

September 22, 2018

Presentation TCT 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Presenter: Fernando Alfonso, Azeem Latib

September 22, 2018

Presentation TCT 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presenter: Fernando Alfonso, Azeem Latib, Antonio Colombo

September 22, 2018

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Daily News

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

Yael L. Maxwell

May 21, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Caitlin E. Cox

May 09, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

News Daily News

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Yael L. Maxwell

February 20, 2018

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Caitlin E. Cox

January 08, 2018

News Daily News

Spending More Won’t Necessarily Improve Acute MI Outcomes

Todd Neale

December 22, 2017

STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis

News Daily News

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Caitlin E. Cox

December 15, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News TCT 2017

CrossBoss First Shows Promise for Antegrade CTO PCI

TCT Daily Staff

November 07, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2017

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

Presenter: Sahil A. Parikh, Thomas Zeller

November 01, 2017

Advertisement

Role of Brachytherapy for Refractory ISR in 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Spending More Won’t Necessarily Improve Acute MI Outcomes

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

CrossBoss First Shows Promise for Antegrade CTO PCI

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content